Skip to main content
رجوع
Watch Compare

Adicet Bio, Inc.

جودة البيانات: 83%
ACET
Nasdaq Manufacturing Chemicals
KWD 6.90
▲ KWD 0.35 (5.34%)
القيمة السوقية: 66.24 M
السعر
KWD 6.90
القيمة السوقية
66.24 M
نطاق اليوم
KWD 6.51 — KWD 6.97
نطاق 52 أسبوعًا
KWD 6.01 — KWD 17.44
حجم التداول
181,601
فتح KWD 6.55
متوسط 50 يوم / 200 يوم
KWD 7.26
4.90% below
متوسط 50 يوم / 200 يوم
KWD 10.11
31.75% below

Quick Summary

النقاط الرئيسية

Negative free cash flow of -96.98 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-96.33%
أقل من متوسط القطاع (-51.02%)
ROIC-72.15%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio5.62
Interest Coverage-3392.06

التقييم

PE (TTM)
-0.57
أعلى من متوسط القطاع (-1.98)
P/B Ratio0.61
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (44 نظير)
المقياس السهم وسيط القطاع
P/E -0.6 -2.0
P/B 0.6 5.1
ROE % -96.3 -51.0
Net Margin % — -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -116.80 M
ROE -96.33% ROA -76.98%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -96.98 M
ROIC -72.15% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 5.62
Interest Coverage -3392.06 Asset Turnover N/A
Working Capital 87.55 M Tangible Book Value 109.14 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.57 Forward P/E N/A
P/B Ratio 0.61 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -146.41%
Market Cap 66.24 M Enterprise Value 37.14 M
Per Share
EPS (Diluted TTM) -16.95 Revenue / Share N/A
FCF / Share -10.10 OCF / Share -9.92
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 83.03%
SBC-Adj. FCF -112.38 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -116.80 M -117.12 M -142.66 M -69.79 M -62.00 M
EPS (Diluted) -16.95 -1.33 -3.31 -1.70 —
Gross Profit — — — — —
Operating Income -122.11 M -127.62 M -152.04 M -72.55 M -61.43 M
EBITDA — — — — —
R&D Expenses 99.13 M 99.32 M 106.04 M 71.25 M 48.94 M
SG&A Expenses — — — — —
D&A 6.38 M 6.47 M 6.10 M 2.58 M 1.54 M
Interest Expense 36,000.0 4,000.0 25,000.0 80,000.0 176,000.0
Income Tax 0.0 0.0 0.0 0.0 -125,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 192.36 M 220.22 M 207.30 M 330.69 M 338.94 M
Total Liabilities 33.15 M 33.61 M 37.12 M 38.35 M 35.81 M
Shareholders' Equity 159.21 M 186.61 M 170.18 M 292.34 M 303.13 M
Total Debt — — — — —
Cash & Equivalents 38.92 M 56.50 M 159.71 M 257.66 M 277.54 M
Current Assets 160.93 M 180.14 M 162.27 M 261.04 M 282.44 M
Current Liabilities 21.53 M 19.39 M 19.29 M 19.71 M 16.32 M